We are live on ! Find out more
TRIB

Trinity Biotech

64 hedge funds and large institutions have $191M invested in Trinity Biotech in 2013 Q2 according to their latest regulatory filings, with 64 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less call options, than puts

Call options by funds: $169K | Put options by funds: $337K

Holders
64
Holders Change
+64
Holders Change %
% of All Funds
2.09%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.13%
New
64
Increased
Reduced
Closed
Calls
$169K
Puts
$337K
Net Calls
-$168K
Net Calls Change
-$168K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$36M +$35.4M +427,150 New
HA
2
Heartland Advisors
Wisconsin
$26.4M +$26M +313,940 New
William Blair & Company
3
William Blair & Company
Illinois
$12.2M +$12M +144,453 New
AAM
4
ACK Asset Management
Connecticut
$11.1M +$10.9M +131,420 New
CIP
5
Chartwell Investment Partners
Pennsylvania
$8.94M +$8.8M +106,121 New
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$7.7M +$7.58M +91,439 New
PWAM
7
Park West Asset Management
California
$7.56M +$7.44M +89,683 New
KCM
8
Kennedy Capital Management
Missouri
$6.83M +$6.73M +81,103 New
Renaissance Technologies
9
Renaissance Technologies
New York
$6.83M +$6.72M +81,010 New
LSC
10
Lyon Street Capital
California
$6.22M +$6.12M +73,772 New
GCM
11
Goldman Capital Management
New York
$5.78M +$5.69M +68,600 New
RA
12
Royce & Associates
New York
$5.66M +$5.57M +67,160 New
Allianz Asset Management
13
Allianz Asset Management
Germany
$3.5M +$3.45M +41,598 New
WA
14
Whitebox Advisors
Minnesota
$3.19M +$3.14M +37,832 New
SKK
15
Shepherd Kaplan Krochuk
Massachusetts
$2.8M +$2.75M +33,207 New
JRJ
16
Jeffrey R. Jay
$2.75M +$2.71M +32,628 New
ARM
17
Adirondack Research & Management
New York
$2.72M +$2.68M +32,301 New
OSAM
18
O'Shaughnessy Asset Management
Connecticut
$2.69M +$2.64M +31,814 New
BCM
19
BBT Capital Management
Texas
$2.53M +$2.49M +30,000 New
Boston Partners
20
Boston Partners
Massachusetts
$2.45M +$2.41M +29,055 New
DGHMC
21
Dalton, Greiner, Hartman, Maher & Co
New York
$2.44M +$2.41M +29,020 New
CCM
22
Corsair Capital Management
New York
$2.29M +$2.25M +27,184 New
TA
23
Teton Advisors
New York
$2.11M +$2.07M +25,000 New
UCFA
24
United Capital Financial Advisors
Texas
$1.88M +$1.85M +22,300 New
GA
25
Geneva Advisors
Illinois
$1.74M +$1.71M +20,627 New

TRIB Hedge Fund Activity: Q2 2013 in Review

64 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q2 2013, worth a combined $191M.

Buyers outnumbered sellers: 64 funds opened new TRIB positions and 0 closed out — a net gain of 64 holders — while 0 added to existing stakes and 0 trimmed.

  • 64 institutional investors held Trinity Biotech (TRIB) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $191M of Trinity Biotech stock for Q2 2013.
  • 64 funds opened new Trinity Biotech positions in Q2 2013 and 0 closed out, a net change of +64 holders.

Based on aggregated 13F filings for Q2 2013.